Introduction
Michigan holds an unusual position among states dealing with substance use disorder (SUD). It has recorded some of the highest overdose mortality rates in the country, yet it has also passed aggressive policies that have reduced fatalities in consecutive years. Residential rehabilitation, defined as intensive therapeutic programming delivered within a 24-hour supervised, substance-free environment (de Andrade et al., 2019), is a key tier in Michigan’s treatment continuum.
This article looks at the epidemiological burden that drives demand for residential services in the state, weighs the evidence for residential treatment efficacy, and examines the regulatory and Medicaid policy structure that shapes how Michigan residents get to these services.
Residential addiction treatment changes lives by offering comprehensive care and resources for long-term recovery. The setting builds a supportive environment for breaking the cycle of substance use, which gives people a real chance at lasting change.
Many programs across the country now use strategies that address not just addiction but the whole person. If you want more detail on this approach, review options such as Residential Rehab in Michigan for an overview of supportive residential treatment environments. Through a structured experience, participants get consistent support, an individualized plan, and the security of 24-hour care as they work toward healing.
With evidence-based practices and community engagement, modern facilities are built to help residents make real progress. Recovery is never a one-size-fits-all process, which is why centers adapt to the different needs of each person who walks in. Treatment plans combine therapy, medical care, and personal development activities to confront the underlying causes of addiction.
These centers also plan for long-term success by building family education, relapse prevention skills, and aftercare planning into their programs. The main goal is sustained sobriety and better well-being, backed by a supportive network. Addiction often occurs alongside mental health conditions, and the best programs treat both at once, coordinating counselors, medical staff, and families to tailor care in every phase of treatment.
The epidemiological imperative
Michigan’s substance use crisis has been driven mostly by opioids, with synthetic variants, particularly illicitly manufactured fentanyl, accounting for the majority of fatal overdoses. In 2021, the state recorded 3,096 overdose deaths, a 13% increase from the 2,738 deaths registered in 2020 (Michigan Department of Health and Human Services [MDHHS], 2023).
Provisional data for 2022 indicated roughly 2,998 fatalities, with opioids implicated in about 80% of cases (MDHHS, 2023). Synthetic opioids were involved in 72.5% of all drug overdose deaths in 2023, a figure that shows how far fentanyl dominates the state’s illicit drug supply (MDHHS, 2025).
The trajectory has begun to shift, though. Provisional data from the Michigan Department of Health and Human Services indicates a 34% reduction in overdose deaths between 2023 and 2024, roughly 1,000 fewer fatalities, the third consecutive year of decline (Michigan Attorney General, 2025).
This improvement has been credited to sustained investment in prevention, treatment expansion, harm reduction infrastructure, and over $1.6 billion in opioid litigation settlements secured since 2019 (Michigan Attorney General, 2025). Geographic disparities still remain, with Wayne and Genesee Counties recording the highest overdose rates between 2019 and 2023 (MDHHS, 2025).
Comprehensive assessment and individualized treatment plans
Residential addiction treatment starts with a thorough, individualized assessment. Licensed clinicians evaluate every new resident, reviewing their medical history, social background, co-occurring disorders, trauma exposures, and the strengths they can draw on during recovery. This evaluation is the foundation for a treatment plan built around each client’s specific challenges and circumstances.
Personalized planning matches therapy, medication management, and skill development to what each person actually needs. By focusing on root causes rather than surface symptoms, a careful assessment helps map a workable path toward sobriety. The National Institute on Drug Abuse reports that individualized plans raise client engagement and the odds of maintaining long-term recovery, because they address the specific factors behind each person’s struggles.
Integrated mental health services
Effective addiction treatment programs now fully integrate mental health support with substance use care. Data consistently show that many people struggling with addiction also face mental health disorders such as depression or anxiety. When both are treated at the same time, outcomes improve markedly.
Comprehensive programs offer both therapy and psychiatric services on-site, which keeps communication among care providers clear and keeps support uninterrupted. This reduces the risk of relapse by making sure mental health needs are diagnosed and met. Facilities create a supportive setting where clients can work through distress, learn healthy coping strategies, and build resilience as they pursue recovery.
Evidence for residential treatment efficacy
The empirical basis for residential rehabilitation rests on a growing but methodologically mixed literature. De Andrade et al. (2019) conducted a systematic review of 23 studies published between 2013 and 2018 and found moderate-quality evidence that residential treatment reduces substance use and improves mental health outcomes.
Of the 17 studies reporting substance use outcomes, 16 showed statistically significant positive effects, with reductions observed across one-, three-, six-, and twelve-month follow-up intervals. Seventeen studies also reported mental health outcomes, including psychological distress, depression, anxiety, and post-traumatic stress disorder, with 16 showing significant improvements.
Marchand et al. (2021) clarified the role of treatment duration. Their meta-analysis showed that people receiving planned long-term treatment or support (18 months or more) had a 23.9% greater probability of achieving abstinence or moderate consumption than those receiving shorter standard interventions (OR = 1.347, 95% CI: 1.087 to 1.668, p < .006). This matches earlier longitudinal evidence that longer residential stays are associated with less substance use, better employment outcomes, and reduced criminal justice involvement (Simpson et al., 1997; Gossop et al., 1999).
De Andrade et al. (2019) also concluded that best-practice residential treatment includes concurrent mental health services and continuity of care after discharge, a point that matters directly in Michigan, where dual diagnosis is common among people seeking treatment.
Family involvement and support
Family involvement is central to successful addiction recovery. Most residential programs invite and support the participation of loved ones through structured family therapy sessions, educational workshops, and support groups. When families learn about addiction and pick up new communication skills, they become sources of encouragement and accountability.
Healing the family as a whole matters, because addiction often damages relationships and leaves trust issues and emotional scars. By helping families repair those relationships, treatment programs create a stronger, healthier support network at home, which lowers the risk of relapse and aids lasting recovery. The Substance Abuse and Mental Health Services Administration (SAMHSA) points to family therapy as a proven element of lasting recovery.
Holistic and experiential therapies
Healing from addiction means addressing the mind, body, and spirit together. Residential centers now often offer yoga, meditation, mindfulness training, art and music therapy, and nutrition counseling. These activities support emotional regulation, build self-awareness, and teach healthier responses to stress.
Experiential therapies, including adventure-based outings, role-playing, or expressive arts, give clients hands-on chances to rebuild confidence. They also open up new ways of relating to peers, encouraging teamwork and personal growth during recovery.
Practice models in Michigan
A survey of 66 residential treatment programs in Michigan by Hightower et al. (2023) found that 67.85% of responding facilities used both harm reduction and abstinence-based frameworks, a move away from the historically dominant abstinence-only model. This matters because harm reduction has strong empirical support internationally and improves treatment engagement among populations that would otherwise stay untreated (Hightower et al., 2023).
Michigan’s residential treatment infrastructure runs from short-term 14- to 30-day programs to longer-term therapeutic communities extending to 90 days or more. The state’s treatment network includes facilities with national quality designations. Henry Ford Maplegrove Center was the first Michigan residential addiction program to receive Blue Distinction Center recognition for substance use treatment, based on outcome quality and patient experience metrics (Henry Ford Health, 2024). The University of Michigan Addiction Center, running since 1988, conducts over two dozen federally funded studies spanning prevention, genetics, brain imaging, and treatment outcomes, which makes the state a significant contributor to the national research base (University of Michigan, 2024).
Medicaid policy and the Section 1115 waiver
One structural factor in residential treatment access in Michigan is the state’s Section 1115 Behavioral Health Demonstration Waiver, approved by the Centers for Medicare & Medicaid Services (CMS) in April 2019. The waiver let Michigan receive federal Medicaid matching funds for SUD services delivered in Institutions for Mental Disease (IMDs), facilities with more than 16 beds that had previously been excluded from federal reimbursement under the longstanding IMD exclusion (CMS, 2019).
The demonstration required Michigan to put in place residential provider standards aligned with the American Society of Addiction Medicine (ASAM) criteria, expand access to medications for opioid use disorder (MOUD) within residential settings, and build a full continuum of care from medically supervised withdrawal through post-discharge recovery support (CMS, 2019). Grogan et al. (2026) noted that 25 of 30 states with approved Section 1115 demonstrations included explicit requirements for MOUD access in residential facilities, with Michigan among the states integrating those requirements most fully.
Fry et al. (2022) assessed Michigan’s mid-point progress and found both advances and lasting problems. The waiver expanded residential capacity and formalized ASAM-based placement criteria, but transportation barriers and the uneven geographic spread of providers still blocked access, especially for rural beneficiaries and those needing methadone, which requires onsite dosing.
Zhang et al. (2025) later showed, through a staggered difference-in-differences analysis of 20 waiver states including Michigan, that SUD waiver implementation was associated with more Medicaid-paid residential treatment stays and less high-acuity inpatient care, though the size of the effect varied a lot across states.
Aftercare and continuous support
The move from residential treatment back to everyday life is a vulnerable time, so the best programs plan for ongoing support well before a client is discharged. Aftercare services include continued outpatient therapy, access to alumni support groups, and connections with sober living homes. These options help people stay accountable and keep growing after they leave the structured setting.
Regular check-ins, follow-up calls, and community activities build a sense of belonging that counters isolation, one of the leading risk factors for relapse. A strong aftercare network gives clients a bridge between intensive treatment and independent life.
Using technology in treatment
Modern residential programs increasingly use technology to reach more clients and support ongoing care. From mobile apps offering cognitive-behavioral tools to telehealth therapy sessions, technology widens access and adds flexibility.
People can now attend appointments from home, connect with counselors as they talk, and use apps to track progress and reach coping strategies at any hour. Digital tools have cut geographic barriers for people in rural or underserved areas and open new ways to get support beyond in-person care. Technology lets clients get care that fits their schedules and preferences, which makes recovery tools more useful and easier to reach.
Challenges and open questions
Even with measurable progress, Michigan’s residential treatment system faces structural problems. Attrition bias remains a major methodological limit in treatment outcome research; people who complete follow-up assessments tend to be the better-functioning subset of program participants (de Andrade et al., 2019).
Racial disparities deepen the crisis. In 2024, 33.1% of SUD treatment episodes among Black non-Hispanic residents ended in discharge without stable housing, compared with 19.9% among white non-Hispanic residents (MDHHS, 2025). Post-discharge mortality risk, especially among people with opioid use disorder whose tolerance has dropped during residential treatment, remains a serious concern in the current fentanyl-saturated drug supply.
Conclusion
Residential addiction treatment is adapting to the complexities of recovery by pairing evidence-based practices with real support systems. Facilities that use individualized assessment, integrated mental health care, family therapy, holistic approaches, and technology give people the best chance at sustained change. With that kind of care, people are better placed to regain control of their lives and hold onto lasting sobriety, backed by a network that attends to every part of their health.
Michigan’s residential rehabilitation picture reflects both the severity of the state’s substance use crisis and the care built into its policy response. Medicaid waiver reform, ASAM-standardized care, declining overdose mortality, and a growing evidence base together make Michigan a useful case study in how state-level infrastructure shapes residential treatment access and outcomes.
The evidence supports residential rehabilitation as an effective option for people with severe and complex SUDs, provided it integrates mental health treatment, offers enough duration, includes MOUD where indicated, and keeps solid continuity of care after discharge.
References
CMS (Centers for Medicare & Medicaid Services). (2019). Michigan Section 1115 Behavioral Health Demonstration Waiver approval. U.S. Department of Health and Human Services. https://www.medicaid.gov/medicaid/section-1115-demo/demonstration-and-waiver-list/82141
de Andrade, D., Elphinston, R. A., Quinn, C., Allan, J., & Hides, L. (2019). The effectiveness of residential treatment services for individuals with substance use disorders: A systematic review. Drug and Alcohol Dependence, 201, 227-235. https://doi.org/10.1016/j.drugalcdep.2019.03.031
Fry, C. E., Benson, R., Bogen, D., Chakraborty, A., & Soper, M. H. (2022). Mid-point assessment of Michigan’s Section 1115 Substance Use Disorder Waiver. Centers for Medicare & Medicaid Services. https://www.medicaid.gov/medicaid/section-1115-demonstrations/downloads/mi-behavioral-health-accepted-mid-point-assessment.pdf
Gossop, M., Marsden, J., Stewart, D., & Rolfe, A. (1999). Treatment retention and 1 year outcomes for residential programmes in England. Drug and Alcohol Dependence, 57(2), 89-98. https://doi.org/10.1016/S0376-8716(99)00086-1
Grogan, C. M., Lin, L. A., Andrews, C. M., Abraham, A. J., Humphreys, K., & Pollack, H. A. (2026). Section 1115 Substance Use Disorder Waivers: Opportunities and limitations. Journal of Health Politics, Policy and Law, 51(1), 83-114. https://doi.org/10.1215/03616878-11584230
Hightower, L., Kent, E., Kumar, V., Michie, L., King, A., & Marshall, T. (2023). A survey of practice models and outcomes in Michigan residential substance use disorder treatment. Journal of Social Work in the Global Community, 8(1), Article 4. https://scholarworks.waldenu.edu/jswgc/vol8/iss1/4/
Marchand, K., Beaumont, S., Engel, J., Haist, B., Marsh, D. C., & Oviedo-Joekes, E. (2021). A systematic review and meta-analysis of the efficacy of the long-term treatment and support of substance use disorders. Social Science & Medicine, 285, 114273. https://doi.org/10.1016/j.socscimed.2021.114273
Michigan Attorney General. (2025, June 5). Michigan projects third consecutive year of decline in opioid overdose deaths [Press release]. https://www.michigan.gov/ag/news/press-releases/2025/06/05/michigan-projects-third-consecutive-year-of-decline-in-opioid-overdose-deaths
Michigan Department of Health and Human Services. (2023). 2023 MDHHS opioid annual report. https://www.michigan.gov/opioids/opioids/-/media/Project/Websites/opioids/documents/2023_Opioids_Report-ver-2.pdf
Michigan Department of Health and Human Services. (2025). Opioid and Substance Use Disorder statewide integrated gap analysis and needs assessment (2023-2025). https://www.michigan.gov/opioids
Simpson, D. D., Joe, G. W., & Brown, B. S. (1997). Treatment retention and follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behaviors, 11(4), 294-307. https://doi.org/10.1037/0893-164X.11.4.294
Zhang, H., Wen, H., & Cummings, J. R. (2025). The impacts of 1115 Medicaid Substance Use Disorder Waivers on Medicaid-paid use of residential treatment and other types of services in 20 states. Health Services Research, 60(4), e14486. https://doi.org/10.1111/1475-6773.14486
